94 related articles for article (PubMed ID: 8821002)
1. Determination of the thickness of the fixed aqueous layer around polyethyleneglycol-coated liposomes.
Shimada K; Miyagishima A; Sadzuka Y; Nozawa Y; Mochizuki Y; Ohshima H; Hirota S
J Drug Target; 1995; 3(4):283-9. PubMed ID: 8821002
[TBL] [Abstract][Full Text] [Related]
2. Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin.
Sadzuka Y; Sugiyama I; Tsuruda T; Sonobe T
Int J Pharm; 2006 Apr; 312(1-2):83-9. PubMed ID: 16457972
[TBL] [Abstract][Full Text] [Related]
3. Correlation of fixed aqueous layer thickness around PEG-modified liposomes with in vivo efficacy of antitumor agent-containing liposomes.
Sugiyama I; Sadzuka Y
Curr Drug Discov Technol; 2011 Dec; 8(4):357-66. PubMed ID: 22034853
[TBL] [Abstract][Full Text] [Related]
4. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
Lopez-Barcons LA; Polo D; Reig F; Fabra A
J Biomed Mater Res A; 2004 Apr; 69(1):155-63. PubMed ID: 14999763
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-encapsulated thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): drug release behavior and stability in the presence of serum.
Han HD; Shin BC; Choi HS
Eur J Pharm Biopharm; 2006 Jan; 62(1):110-6. PubMed ID: 16183268
[TBL] [Abstract][Full Text] [Related]
6. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
[TBL] [Abstract][Full Text] [Related]
7. The effect of dose on the distribution of adriamycin encapsulated in polyethyleneglycol-coated liposomes.
Sadzuka Y; Nakai S; Miyagishima A; Nozawa Y; Hirota S
J Drug Target; 1995; 3(1):31-7. PubMed ID: 7655818
[TBL] [Abstract][Full Text] [Related]
8. Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines.
Zeisig R; Shimada K; Hirota S; Arndt D
Biochim Biophys Acta; 1996 Dec; 1285(2):237-45. PubMed ID: 8972708
[TBL] [Abstract][Full Text] [Related]
9. The phototoxicity of photofrin was enhanced by PEGylated liposome in vitro.
Sadzuka Y; Tokutomi K; Iwasaki F; Sugiyama I; Hirano T; Konno H; Oku N; Sonobe T
Cancer Lett; 2006 Sep; 241(1):42-8. PubMed ID: 16303246
[TBL] [Abstract][Full Text] [Related]
10. Phototoxicity of coproporphyrin as a novel photodynamic therapy was enhanced by liposomalization.
Sadzuka Y; Iwasaki F; Sugiyama I; Horiuchi K; Hirano T; Ozawa H; Kanayama N; Oku N
Toxicol Lett; 2008 Nov; 182(1-3):110-4. PubMed ID: 18835340
[TBL] [Abstract][Full Text] [Related]
11. [To Assess Drug Delivery System Nanocarrier at Industrial Production: Establishment of Liposomal Surface Using Physicochemical Properties].
Sadzuka Y
Yakugaku Zasshi; 2024; 144(1):61-69. PubMed ID: 38171797
[TBL] [Abstract][Full Text] [Related]
12. Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome.
Sadzuka Y; Nakade A; Hirama R; Miyagishima A; Nozawa Y; Hirota S; Sonobe T
Int J Pharm; 2002 May; 238(1-2):171-80. PubMed ID: 11996821
[TBL] [Abstract][Full Text] [Related]
13. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
14. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
Masunaga S; Kasaoka S; Maruyama K; Nigg D; Sakurai Y; Nagata K; Suzuki M; Kinashi Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1515-22. PubMed ID: 17126210
[TBL] [Abstract][Full Text] [Related]
15. The encapsulation and release of guanosine from PEGylated liposomes.
Er Y; Barnes TJ; Fornasiero D; Prestidge CA
J Liposome Res; 2009; 19(1):29-36. PubMed ID: 19515005
[TBL] [Abstract][Full Text] [Related]
16. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome.
Maeda N; Takeuchi Y; Takada M; Sadzuka Y; Namba Y; Oku N
J Control Release; 2004 Nov; 100(1):41-52. PubMed ID: 15491809
[TBL] [Abstract][Full Text] [Related]
17. Physico-chemical properties and cytotoxicity assessment of PEG-modified liposomes containing human hemoglobin.
Centis V; Vermette P
Colloids Surf B Biointerfaces; 2008 Sep; 65(2):239-46. PubMed ID: 18538549
[TBL] [Abstract][Full Text] [Related]
18. Change in the character of liposomes as a drug carrier by modifying various polyethyleneglycol-lipids.
Sugiyama I; Sadzuka Y
Biol Pharm Bull; 2013; 36(6):900-6. PubMed ID: 23727913
[TBL] [Abstract][Full Text] [Related]
19. [An importance of colloid chemical characterization of liposomes for DDS in a large scale production].
Hirota S
Yakugaku Zasshi; 1997 Dec; 117(12):991-1005. PubMed ID: 9437906
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method.
Qiu L; Jing N; Jin Y
Int J Pharm; 2008 Sep; 361(1-2):56-63. PubMed ID: 18573626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
